Tafnat EM 200mg/25mg Tablet

Overview Tafnat EM 200mg/25mg Tablet

Combivir 200mg/25mg tablets are classified as antiretroviral medications, employed in the management of HIV (human immunodeficiency virus) infection, the causative agent of AIDS (acquired immunodeficiency syndrome). This medication assists in controlling the HIV viral load, thereby bolstering your immune system's function. It's crucial to understand that Combivir 200mg/25mg tablets do not cure HIV/AIDS; rather, they reduce the viral count, mitigating the risk of HIV-related complications and potentially extending lifespan. It may also be prophylactically prescribed for individuals at high risk of infection. Administration may be solo or in conjunction with other antiretroviral therapies, with dosage determined by your physician. Adhere strictly to prescribed medication regimens. Optimal absorption is achieved when taken with food. Consistent, timely medication intake is crucial for efficacy and resistance prevention. Omitting doses should be avoided; continue treatment until medically advised otherwise. Common adverse effects include nausea, diarrhea, headache, insomnia, skin rash, and vertigo. While typically mild, persistent or bothersome symptoms warrant medical attention. Long-term use may increase the risk of osteoporosis; regular exercise and calcium/vitamin D supplementation, as directed by your doctor, are recommended. Weight gain is a potential side effect. Prior to commencing treatment, inform your doctor of any pre-existing liver, kidney, or bone conditions. Regular blood tests to monitor blood cell counts, liver and kidney function will likely be required. Dizziness or drowsiness may impair driving ability; avoid driving if affected. Pregnant or breastfeeding individuals must consult their physician before use. Safe sex practices, including consistent condom use, and avoidance of sharing personal items are vital to prevent HIV transmission if you are HIV positive.

Uses of Tafnat EM 200mg/25mg Tablet

Human immunodeficiency virus infection

Major Benefits of Tafnat EM 200mg/25mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tafnat EM 200mg/25mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Tafnat EM 200mg/25mg Tablet:

• Nausea
• Diarrhea
• Headache
• Depression
• Rash
• Dizziness
• Fatigue
• Vomiting
• Insomnia (difficulty in sleeping)
• Weakness
• Allergic reaction
• Abnormal dreams
• Decreased phosphate level in blood
• Decreased white blood cell count (neutrophils)
• Increased triglyceride level in blood
• Abdominal pain
• Weight loss
• Increased transaminase level in blood
• Increased glucose level in blood
• Elevated levels of serum amylase
• Increased lipase in the blood
• Elevated creatinine kinase

How to use Tafnat EM 200mg/25mg Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consume Tafnat EM 200mg/25mg tablets with food.

How Tafnat EM 200mg/25mg Tablet works:

Emtricitabine/Tenofovir disoproxil fumarate 200mg/25mg (Tafnat EM) tablets combine two antiretroviral agents to combat HIV. This medication works by inhibiting HIV replication, thus lowering the viral load. Concurrently, it elevates CD4+ T-lymphocyte counts, bolstering the immune system's defenses.

What if you forget to take Tafnat EM 200mg/25mg Tablet :

Should you forget a Tafnat EM 200mg/25mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.